Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Amperozide (FG 5606) 是一种非典型抗精神病药,可拮抗5-HT2A 受体。它抑制多巴胺的释放并改变多巴胺能神经元的放电。关于该药物使用的调查主要围绕其治疗人类精神分裂症的能力展开。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 752 | 现货 | ||
5 mg | ¥ 1,860 | 现货 | ||
10 mg | ¥ 2,980 | 现货 | ||
25 mg | ¥ 4,830 | 现货 | ||
50 mg | ¥ 6,690 | 现货 | ||
100 mg | ¥ 8,870 | 现货 |
产品描述 | Amperozide (FG 5606) is a diphenylbutylpiperazine atypical antipsychotic which antagonizes 5-HT2A receptors. It inhibits dopamine release and alters the firing of dopaminergic neurons. Investigations regarding the use of the agent revolved primarily around its capability for treating schizophrenia in humans. |
体外活性 | Amperozide inhibited the amphetamine-stimulated release of dopamine from perfused rat striatal tissue in a dose-dependent manner. With 1 and 10 microM amperozide there was significant inhibition of the amphetamine-stimulated release of dopamine, to 44 and 36% of control. In contrast, 10 microM amperozide significantly strengthened the electrically stimulated release of dopamine from perfused striatal slices. Amperozide 1-10 microM had no significant effect on the potassium-stimulated release of dopamine. 10 microM amperozide also slightly increased the basal release of 3H-dopamine from perfused striatal tissue[1]. |
别名 | FG 5606, 安哌齐持, Amperozida, Amperozidum |
分子量 | 401.49 |
分子式 | C23H29F2N3O |
CAS No. | 75558-90-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/ml (99.63 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4907 mL | 12.4536 mL | 24.9072 mL | 62.2681 mL |
5 mM | 0.4981 mL | 2.4907 mL | 4.9814 mL | 12.4536 mL | |
10 mM | 0.2491 mL | 1.2454 mL | 2.4907 mL | 6.2268 mL | |
20 mM | 0.1245 mL | 0.6227 mL | 1.2454 mL | 3.1134 mL | |
50 mM | 0.0498 mL | 0.2491 mL | 0.4981 mL | 1.2454 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Amperozide 75558-90-6 GPCR/G Protein Neuroscience 5-HT Receptor FG 5606 FG-5606 FG5606 安哌齐持 Amperozida Amperozidum Inhibitor inhibitor inhibit